Michael Coslovsky
Overview
Explore the profile of Michael Coslovsky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
932
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Iten V, Herber E, Coslovsky M, Hennings E, Paladini R, Reichlin T, et al.
BMC Med
. 2024 Dec;
22(1):593.
PMID: 39696255
Background: There is some evidence of reduced major cardiovascular event (MACE) rates associated with moderate coffee consumption in the general population. However, there is concern about the potential risks of...
2.
Schweigler A, Hennings E, Aeschbacher S, Carmine D, Reichlin T, Rodondi N, et al.
J Intern Med
. 2024 Nov;
297(3):335-338.
PMID: 39601166
No abstract available.
3.
Peter R, Aeschbacher S, Paladini R, Coslovsky M, Krisai P, Schweigler A, et al.
Am J Cardiol
. 2024 Nov;
237():72-78.
PMID: 39579917
Cigarette smoking and atrial fibrillation (AF) are associated with impaired brain health. We investigated the association between smoking habits and brain lesions and volume in patients with AF. In patients...
4.
Carmine D, Aeschbacher S, Coslovsky M, Hennings E, Paladini R, Peter R, et al.
Front Cardiovasc Med
. 2024 Sep;
11:1449506.
PMID: 39314770
Background: The influence of atrial fibrillation (AF) and blood pressure (BP) on brain lesions and cognitive function is unclear. We aimed to investigate the association of BP with different types...
5.
Hennings E, Aeschbacher S, Coslovsky M, Paladini R, Voellmin G, Lampart M, et al.
Clin Res Cardiol
. 2024 Sep;
114(2):239-250.
PMID: 39297942
Background And Aims: The role of biomarkers in diagnosing pulmonary hypertension (PH) and distinguishing between pre- and post-capillary PH remains poorly understood. We aimed to identify biomarkers with a strong...
6.
Hammerle P, Aeschbacher S, Schlageter V, Coslovsky M, Hennings E, Krisai P, et al.
Heart Rhythm
. 2024 May;
21(9):1509-1516.
PMID: 38762133
Background: Stroke remains one of the most serious complications in atrial fibrillation (AF) patients and has been linked to disturbances of the autonomic nervous system. Objective: The purpose of this...
7.
Aebersold H, Foster-Witassek F, Aeschbacher S, Beer J, Blozik E, Blum M, et al.
Open Heart
. 2024 Feb;
11(1).
PMID: 38302139
Aims: Direct-acting oral anticoagulants (DOACs) have, to a substantial degree, replaced vitamin K antagonists (VKA) as treatments for stroke prevention in atrial fibrillation (AF) patients. However, evidence on the real-world...
8.
Foster-Witassek F, Aebersold H, Aeschbacher S, Ammann P, Beer J, Blozik E, et al.
J Am Heart Assoc
. 2023 Nov;
12(21):e031872.
PMID: 37929709
Background Optimizing health-related quality of life (HRQoL) is an important aim of atrial fibrillation (AF) treatment. Little is known about patients' long-term HRQoL trajectories and the impact of patient and...
9.
Serra-Burriel M, Aebersold H, Foster-Witassek F, Coslovsky M, Rodondi N, Blum M, et al.
Value Health
. 2023 Sep;
26(12):1721-1729.
PMID: 37741443
Objectives: Randomized controlled trials of pulmonary vein isolation (PVI) for treating atrial fibrillation (AF) have proven the procedure's efficacy. Studies assessing its empirical cost-effectiveness outside randomized trial settings are lacking....
10.
Wueest A, Zuber P, Coslovsky M, Rommers N, Rodondi N, Gencer B, et al.
Front Cardiovasc Med
. 2023 Aug;
10:1212587.
PMID: 37600058
Background: Longitudinal association studies of atrial fibrillation (AF) and cognitive functions have shown an unclear role of AF-type and often differ in methodological aspects. We therefore aim to investigate longitudinal...